Skip to content

Technology
Pipeline
Team
Partnership
Publications
Contact us

The magic of small-moleculedrugs during ex vivo expansionin adoptive cell therapy

Posted on November 6, 2023November 6, 2023 by admin

Posted in Uncategorized

Post navigation

Previous: Targeting vasoactive intestinal peptidemediated signaling enhances response toimmune checkpoint therapy in pancreaticductal adenocarcinoma

Leave a Reply Cancel reply

You must be logged in to post a comment.

Search

Recent Posts

The magic of small-moleculedrugs during ex vivo expansionin adoptive cell therapy
Targeting vasoactive intestinal peptidemediated signaling enhances response toimmune checkpoint therapy in pancreaticductal adenocarcinoma
Comparing VIP and PD-L1 expression as cancer biomarkers
Absence of Vasoactive Intestinal Peptide Expression in Hematopoietic Cells EnhancesAbsence of Vasoactive Intestinal Peptide Th1 Polarization and Antiviral Immunity in Mice
Administration of a vasoactive intestinal peptide antagonist enhances the autologousanti-leukemia T cell response in murine models of acute leukemia

Recent Comments

No comments to show.

Archives

November 2023

Categories

Uncategorized

Technology
Pipeline
Team
Partnership
Publications
Contact us

© 2023 Cambium Oncology. All Rights Reserved